| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/13/2011 | CN1175976B Arachidonic acid and method for production and use thereof |
| 07/13/2011 | CN102124105A Antibody capable of binding specifically to Abeta-oligomer, and use thereof |
| 07/13/2011 | CN102124006A Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 07/13/2011 | CN102124002A Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 07/13/2011 | CN102124001A Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 07/13/2011 | CN102123998A Isoquinolinone derivatives as nk3 antagonists |
| 07/13/2011 | CN102123992A Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 07/13/2011 | CN102123986A Pharmaceutical compositions |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123728A Compounds for treating amyloidoses |
| 07/13/2011 | CN102123727A Compounds for treating beta-amyloidoses |
| 07/13/2011 | CN102123726A Compounds for treating symptoms associated with parkinson's disease |
| 07/13/2011 | CN102123725A Opiorphin for use as a psychostimulant agent |
| 07/13/2011 | CN102123703A 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines |
| 07/13/2011 | CN102120023A Chinese medicinal preparation for treating migraine and preparation method thereof |
| 07/13/2011 | CN102120015A Traditional Chinese medicine for soothing liver and dispersing depressed vital energy and soothing nerves and sedating mind, and preparation method and quality standard thereof |
| 07/13/2011 | CN102120012A Compound preparation comprising American ginseng and alpinia oxyphylla |
| 07/13/2011 | CN102120006A Chinese medicinal formula for treating insomnia |
| 07/13/2011 | CN102120004A Method for preparing heart calming and mind tranquilizing preparation |
| 07/13/2011 | CN102120003A Chinese patent medicine for treating headache |
| 07/13/2011 | CN102119997A Method for establishing HPLC (high performance liquid chromatography) finger-print of ophiopogon japonicus and standard finger-print thereof |
| 07/13/2011 | CN102119987A Traditional Chinese medicine preparation for treating epilepsy |
| 07/13/2011 | CN102119986A Traditional Chinese medicine extract with anti-dementia effect and preparation method thereof |
| 07/13/2011 | CN102119982A Chinese medicinal formula for treating migraine |
| 07/13/2011 | CN102119944A Dammarane type glycoside composition particles |
| 07/13/2011 | CN102119920A Edaravone injection and preparation method thereof |
| 07/13/2011 | CN102119821A Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion |
| 07/13/2011 | CN101837109B Foot-bath effervescent tablet for improving sleep |
| 07/13/2011 | CN101589898B Multifunctional health care Chinese medicament pillow |
| 07/13/2011 | CN101472886B Substituted phenyl methanone derivatives |
| 07/13/2011 | CN101461922B Health-care medicinal wine for treating insomnia |
| 07/13/2011 | CN101347517B Medicine for giving up drug |
| 07/13/2011 | CN101237875B Pharmaceutical compositions comprising a tungsten salt (VI) for the treatment of neurodegenerative disorders, particularly alzheimer's disease and schizophrenia |
| 07/13/2011 | CN101166742B Novel lactam compound |
| 07/13/2011 | CA2727905A1 Method of altering perception of time |
| 07/12/2011 | US7977485 2-heteroaryl carboxamides |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977383 Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives |
| 07/12/2011 | US7977377 Treatment of depressive disorders |
| 07/12/2011 | US7977356 Optical isomers of an Iloperidone metabolite |
| 07/12/2011 | US7977355 N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl |
| 07/12/2011 | US7977337 Quinoline derivatives and their use as 5-HT6 ligands |
| 07/12/2011 | US7977335 Methods of preventing and reducing the severity of stress-associated conditions |
| 07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977314 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 07/12/2011 | US7977307 Method for reducing pain with ziconotide and morphine |
| 07/12/2011 | US7977065 Yeast strains autonomously producing steroids |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2577879C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon. |
| 07/12/2011 | CA2511619C Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 07/12/2011 | CA2499492C Methods of preparing cannabinoids from plant material |
| 07/12/2011 | CA2498275C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 07/12/2011 | CA2483097C Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2480266C Use of an alpha2-adrenoreceptor antagonist for cns-related diseases |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2441744C Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 07/12/2011 | CA2422617C Tripeptidyl peptidase inhibitors |
| 07/12/2011 | CA2419148C Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/12/2011 | CA2364095C Production of radial glial cells |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2312274C Isolated dna encoding human h3 histamine receptor |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011082283A2 Management of myoclonus with oral liposomal reduced glutathione |
| 07/07/2011 | WO2011082111A1 Anaplerotic therapy for alzheimer's disease and the aging brain |
| 07/07/2011 | WO2011082010A1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia |
| 07/07/2011 | WO2011081928A2 Compositions and methods for altering cocaine esterase activity |
| 07/07/2011 | WO2011081567A1 Agent for treating multiple sclerosis |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011080982A1 Oil or fat composition for prevention or treatment of depression or depressed conditions |
| 07/07/2011 | WO2011080947A1 Composition for improving brain function and method for improving brain function |
| 07/07/2011 | WO2011080751A2 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
| 07/07/2011 | WO2011080488A1 Pharmaceutical composition for treating alcohol dependency |
| 07/07/2011 | WO2011080445A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
| 07/07/2011 | WO2011080344A1 Diazoxide for use in the treatment of a central nervous system (cns) autoimmune demyelinating disease |
| 07/07/2011 | WO2011080313A1 Novel piperine derivatives as gaba - a receptors modulators |
| 07/07/2011 | WO2011080203A1 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases |
| 07/07/2011 | WO2011080176A1 Pyrazine derivatives and their use in the treatment of neurological disorders |
| 07/07/2011 | WO2011079841A1 Beta-carbolines for use in the treatment of hearing loss and vertigo |
| 07/07/2011 | WO2011079807A1 Dipropofol pyrophosphate dihydrogen ester and pharmaceutically acceptable salt, preparation process and application thereof |
| 07/07/2011 | WO2011079767A1 Solid formulation of zopiclone and the preparation method thereof |
| 07/07/2011 | WO2011079766A1 Aripiprazole solid preparation and the production method thereof |
| 07/07/2011 | WO2011079764A1 Solid formulation of eszopiclone and the preparation method thereof |
| 07/07/2011 | WO2011060246A3 A method of promoting dendritic spine density |
| 07/07/2011 | WO2011051342A8 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| 07/07/2011 | WO2011032161A8 Vaccines directed to langerhans cells |
| 07/07/2011 | WO2011028799A3 Ganglioside transmucosal formulations |
| 07/07/2011 | WO2011021916A3 Use of egf-like domain of heregulin beta 1 peptide |
| 07/07/2011 | WO2010147803A3 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes |
| 07/07/2011 | WO2010089259A3 Sustained release composition containing quetiapine |
| 07/07/2011 | WO2010067008A3 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |